Clinical trial
Obstructive Sleep Apnea Syndrome in Glaucoma
NCT00313092 · Selim Orguel, Other · Terminated
Key facts
| NCT number | NCT00313092 |
|---|---|
| Title | Obstructive Sleep Apnea Syndrome in Glaucoma |
| Official title | Does Plasma Matrix-metalloproteinase Activity Predict Glaucomas in Patients With OSAS (Obstructive Sleep Apnea Syndrome) and Does the Level of Plasma Matrix-metalloproteinase Activity Decrease After One Month of nCPAP-treatment |
| Lead sponsor | Selim Orguel, Other |
| Collaborators | University Hospital, Basel, Switzerland |
| Status | Terminated |
| Study type | Observational |
| Conditions | Obstructive Sleep Apnea Syndrome, Glaucoma |
| Intervention type | Device |
| Interventions | nCPAP treatment |
| Enrollment | 60 |
| Start date | Jan 1, 2005 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Apr 11, 2006 |
| Last update posted | Oct 2, 2015 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: